Newly-approved plans for office and medical research space point to potential expansion of New Haven’s life science ecosystem at a time when developers in other cities are having trouble filling space in many of the nation’s largest biotech clusters.
State grant funding will help New Haven’s latest new-build life sciences development get out of the ground. Or, more accurately, it will help the project’s developer get the ground out of the site.
A planned life science tower took a significant step forward last week when lab developer Ancora bought a 0.78-acre slice of the former New Haven Coliseum site from the project’s master developer.
